According to Immatics's latest financial reports and stock price the company's current Operating Margin is 31.85%. At the end of 2021 the company had an Operating Margin of -268.49%.
Year | Operating Margin | Change |
---|---|---|
2021 | -268.49% | -63.46% |
2020 | -734.70% | 317.23% |
2019 | -176.09% | -79.48% |
2018 | -858.22% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -234,760.00% | -737,180.06% | Bahamas |
NRC Health
NRC | 32.86% | 3.17% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.